Belgium· BE-AMP-SAM108446-00
Dopram 20 mg/ml
A doxapram product containing doxapram hydrochloride, registered in Belgium by Eumedica Pharmaceuticals. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Doxapram is registered in 9 of 19 countries.
Countries holding a registration under ATC R07AB01 (doxapram), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Doxapram · ATC R07AB01
9 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Doxapram Hydrochloride
- Manufacturer
- Eumedica Pharmaceuticals
- Country
- Belgium (BE)
- ATC code
- R07AB01
- ATC class
- Doxapram
- Defined daily dose
- 0.4 g, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb0037317
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
66 interactions on record for doxapram.
Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Doxapram · interactions on record
66 records
- 20 severe
- 46 moderate
Most severe, free to view
- LinezolidJ01XX08severe
- ProcarbazineL01XB01severe
- OzanimodL04AA38severe
- OzanimodL04AE02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Doxapram in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandDoxapram Hydrochloride 20mg/ml Solution for InjectionMercuryPharm Ltd
- United KingdomDopram 100mg/5ml solution for injection ampoulesMercury Pharma Group Ltd
- FinlandDopram
- United StatesDopramHikma Pharmaceuticals USA Inc.
- FranceDOPRAM 2 POUR CENT, solution injectableEFISCIENS (MALTE)
- GermanyDopramCarinopharm Gmbh
- NorwayDopramCarinopharm
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Dopram
- France · Dopram
- United Kingdom (Northern Ireland) · Dopram, Doxapram Hydrochloride Mercury Pharmaceuticals Limited
- Ireland · Doxapram Hydrochloride Mercurypharm Ltd
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/56ef0149-56ab-4aaa-a517-d5826604c4bf GET /v1/drugs/56ef0149-56ab-4aaa-a517-d5826604c4bf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Dopram 20 mg/ml",
"name_fr": "Dopram 20 mg/ml",
"name_nl": "Dopram 20 mg/ml",
"amp_code": "SAM108446-00",
"strengths": [
"100.0000",
"100.0000"
],
"pack_count": 1,
"substances": [
"Doxapram Hydrochloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Doxapram",
"authorisation_numbers": [
"BE108446"
]
}See everything about doxapram.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.